COVID-19 and "The Remdesivir Crosslet"
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 2 | Views: 300 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Case Studies | Medical Science | India | Volume 10 Issue 12, December 2021 | Popularity: 4.4 / 10


     

COVID-19 and "The Remdesivir Crosslet"

Dr. Adwait Sodani, Dr. Haseena Begum, Dr. SK Nanda


Abstract: Remdesivir has made an alleged comeback (with or without baricitinib) with the dawn of new COVID-19 strains internationally but back here in India it always was supposedly effective. However, not many studies could be published in support of the same (and thus the use of 'supposedly' apropos) from India given the confusing and changing guidelines world-around. Nevertheless, this article emphasizes the fact (by reporting cases of success) that remdesivir sure is effective albeit with the rider being the "timing" which we imagine as an 'appearance of a crosslet' in the fort of COVID-19.


Keywords: COVID-19, remdesivir


Edition: Volume 10 Issue 12, December 2021


Pages: 1155 - 1157


DOI: https://www.doi.org/10.21275/SR211210221525


Please Disable the Pop-Up Blocker of Web Browser

Verification Code will appear in 2 Seconds ... Wait



Text copied to Clipboard!
Dr. Adwait Sodani, Dr. Haseena Begum, Dr. SK Nanda, "COVID-19 and "The Remdesivir Crosslet"", International Journal of Science and Research (IJSR), Volume 10 Issue 12, December 2021, pp. 1155-1157, https://www.ijsr.net/getabstract.php?paperid=SR211210221525, DOI: https://www.doi.org/10.21275/SR211210221525

Top